[The relevance of Choukroun's Platelet-Rich Fibrin (PRF) during middle ear surgery: preliminary results]

F Braccini1, L Tardivet, D M Dohan Ehrenfest

  • 1Institut Azuréen d'ORL et de Chirurgie de la Face, 25 Avenue Jean Médecin, F-06000 Nice, France. contact@braccini.net

Abstract

Insights

Leucocyte- and Platelet-Rich Fibrin (L-PRF) significantly improved tympanoplasty success rates to 96%, compared to the usual 85%. This autologous biomaterial enhances graft healing and offers protection, proving valuable in middle-ear surgery.

Area of Science:

  • Otolaryngology
  • Regenerative Medicine
  • Biomaterials Science

Context:

  • Tympanoplasty aims to repair tympanic membrane perforations.
  • Autologous biomaterials are increasingly explored to enhance surgical outcomes.
  • Leucocyte- and Platelet-Rich Fibrin (L-PRF) is a concentrate derived from the patient's own blood.

Purpose:

  • To evaluate the efficacy of Leucocyte- and Platelet-Rich Fibrin (L-PRF) in improving tympanoplasty success rates.
  • To assess the role of L-PRF in graft protection and healing during tympanoplasty.

Summary:

  • A study of 152 tympanoplasties utilized L-PRF (Choukroun's technique) via "Champagne plug" or "hamburger" techniques.
  • Success rates reached 96% with L-PRF, a significant increase from the typical 85% success rate without PRF.
  • Failures were primarily associated with large, non-marginal perforations.

Impact:

  • L-PRF enhances graft healing by accelerating cell proliferation and matrix remodeling.
  • It provides mechanical and inflammatory protection to the tympanic graft.
  • L-PRF is an easily produced, cost-effective, and well-tolerated autologous biomaterial with potential for broader applications in middle-ear surgery.

Related Concept Videos